# Are peptides safe in pregnancy?

Source: https://pepvault.app/guides/peptides-and-pregnancy

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [Getting started](https://pepvault.app/guides#getting-started)

# Are peptides safe in pregnancy, and before trying to conceive?

Reviewed November 2026 19 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Are peptides safe in pregnancy? Each label's pregnancy and birth-control line in one table, Wegovy to Vyleesi, with half-lives and BPC-157's missing data.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 19
- **Questions:** 7
- **Compounds:** 14

## The short answer

No peptide taken for weight, fat, healing or growth hormone is labelled safe in pregnancy. Tesamorelin is contraindicated; Wegovy, Zepbound and Saxenda say stop once a pregnancy is known; Ozempic and Mounjaro, for diabetes, leave a benefit-risk call. Only the two semaglutide labels set a date: 2 months before a planned pregnancy. BPC-157 and TB-500 have no human pregnancy data. Your prescriber sets the plan.

Every number checked at its primary source · Nov 20, 2026 · [19 sources](https://pepvault.app/guides/peptides-and-pregnancy#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** FDA labels (DailyMed) for twelve approved peptide medicines, with their animal reproduction studies and small human pregnancy counts, and human pharmacokinetic studies for the half-lives; none of the weight, fat, sex-drive, growth-hormone or healing peptides here has been tested in a pregnancy trial, and research peptides have no human pregnancy data.

## Are any peptides used in pregnancy?

Yes, and that is why the word "peptide" alone does not answer the question. A **peptide** is a short chain of amino acids, and two of the most-used medicines in pregnancy are peptides. Insulin is one: the label for Novo Nordisk's insulin aspart notes that randomised trials in the second trimester found no link with major birth defects, while poorly controlled diabetes carries real risks for mother and baby[13](https://pepvault.app/guides/peptides-and-pregnancy#source-13). Oxytocin is the other. Hospitals give it as Pitocin to start or strengthen labour, and its label says that, used as indicated, it would not be expected to cause fetal abnormalities[14](https://pepvault.app/guides/peptides-and-pregnancy#source-14).

So the answer belongs to each drug, not to the class. For the peptides people take for weight, belly fat, sex drive, growth hormone or healing, human pregnancy data are thin or absent, so the labels' warnings rest on animal reproduction studies and, for the weight and fat drugs, on the plain point that losing weight brings a pregnancy no benefit. Most of those labels tell you to stop or avoid them. The research peptides have no label at all.

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault's dose log keeps the date and amount of every dose you log, for each compound, so your last dose is on record when your prescriber asks how long it has been.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What does each peptide's label say about pregnancy and birth control?

Here is the pregnancy and contraception line of every approved peptide people most often ask about, from the FDA labels on DailyMed as of November 20, 2026. A **contraindication** is the strongest word a label has: do not use.

| Label (peptide) | Once pregnant | Before a planned pregnancy | Birth control |
| --- | --- | --- | --- |
| Ozempic (semaglutide, diabetes) | Use only if the benefit justifies the risk to the fetus[1](https://pepvault.app/guides/peptides-and-pregnancy#source-1) | Stop at least 2 months before[1](https://pepvault.app/guides/peptides-and-pregnancy#source-1) | No step on the label[1](https://pepvault.app/guides/peptides-and-pregnancy#source-1) |
| Wegovy (semaglutide, weight) | Stop when pregnancy is recognized; for MASH, a liver disease, only if the benefit justifies the risk[2](https://pepvault.app/guides/peptides-and-pregnancy#source-2) | Stop at least 2 months before; for MASH, when the risk outweighs the benefit[2](https://pepvault.app/guides/peptides-and-pregnancy#source-2) | No step on the label[2](https://pepvault.app/guides/peptides-and-pregnancy#source-2) |
| Mounjaro (tirzepatide, diabetes) | Use only if the benefit justifies the risk to the fetus[3](https://pepvault.app/guides/peptides-and-pregnancy#source-3) | No interval stated[3](https://pepvault.app/guides/peptides-and-pregnancy#source-3) | On the pill: switch to a non-oral method, or add a barrier, for 4 weeks after starting and after each dose increase[3](https://pepvault.app/guides/peptides-and-pregnancy#source-3) |
| Zepbound (tirzepatide, weight) | Stop when pregnancy is recognized[4](https://pepvault.app/guides/peptides-and-pregnancy#source-4) | No interval stated[4](https://pepvault.app/guides/peptides-and-pregnancy#source-4) | The same 4-week pill step as Mounjaro[4](https://pepvault.app/guides/peptides-and-pregnancy#source-4) |
| Saxenda (liraglutide, weight) | Stop when pregnancy is recognized[5](https://pepvault.app/guides/peptides-and-pregnancy#source-5) | No interval stated[5](https://pepvault.app/guides/peptides-and-pregnancy#source-5) | No step; in a pill study, overall estrogen exposure was unchanged[5](https://pepvault.app/guides/peptides-and-pregnancy#source-5) |
| Egrifta SV and WR (tesamorelin) | Contraindicated; stop if pregnancy occurs[6](https://pepvault.app/guides/peptides-and-pregnancy#source-6) [7](https://pepvault.app/guides/peptides-and-pregnancy#source-7) | No interval stated[6](https://pepvault.app/guides/peptides-and-pregnancy#source-6) | No step on the label[6](https://pepvault.app/guides/peptides-and-pregnancy#source-6) |
| Vyleesi (bremelanotide, PT-141) | Stop if pregnancy is even suspected[8](https://pepvault.app/guides/peptides-and-pregnancy#source-8) | No interval stated[8](https://pepvault.app/guides/peptides-and-pregnancy#source-8) | Use effective contraception while taking it[8](https://pepvault.app/guides/peptides-and-pregnancy#source-8) |
| Imcivree (setmelanotide) | Stop when pregnancy is recognized, unless the benefit outweighs the risk[9](https://pepvault.app/guides/peptides-and-pregnancy#source-9) | No interval stated[9](https://pepvault.app/guides/peptides-and-pregnancy#source-9) | No step on the label[9](https://pepvault.app/guides/peptides-and-pregnancy#source-9) |
| Novarel and Pregnyl (hCG) | Novarel: may cause fetal harm; Pregnyl: not indicated, stopped once pregnancy is confirmed[10](https://pepvault.app/guides/peptides-and-pregnancy#source-10) [11](https://pepvault.app/guides/peptides-and-pregnancy#source-11) | A fertility drug: used to bring on ovulation[10](https://pepvault.app/guides/peptides-and-pregnancy#source-10) | No step on the label[10](https://pepvault.app/guides/peptides-and-pregnancy#source-10) |
| Genotropin (somatropin, HGH) | Data too limited to judge a risk[12](https://pepvault.app/guides/peptides-and-pregnancy#source-12) | No interval stated[12](https://pepvault.app/guides/peptides-and-pregnancy#source-12) | No step on the label[12](https://pepvault.app/guides/peptides-and-pregnancy#source-12) |

The pattern follows each drug's job. Where the goal is weight, the labels say plainly that weight loss "offers no benefit to a pregnant patient and may cause fetal harm"[2](https://pepvault.app/guides/peptides-and-pregnancy#source-2) [4](https://pepvault.app/guides/peptides-and-pregnancy#source-4) [5](https://pepvault.app/guides/peptides-and-pregnancy#source-5); Egrifta's says the same of shrinking belly fat[6](https://pepvault.app/guides/peptides-and-pregnancy#source-6). Where the drug treats diabetes, uncontrolled blood sugar is a risk of its own, so the Ozempic and Mounjaro labels leave a weighing of benefit and risk to the prescriber[1](https://pepvault.app/guides/peptides-and-pregnancy#source-1) [3](https://pepvault.app/guides/peptides-and-pregnancy#source-3).

The animal results behind the warnings differ widely. Tesamorelin caused hydrocephaly, fluid on the brain, in rat offspring at about two to four times the clinical exposure[6](https://pepvault.app/guides/peptides-and-pregnancy#source-6). Bremelanotide raised pregnancy loss in dogs at 16 times the human exposure and above[8](https://pepvault.app/guides/peptides-and-pregnancy#source-8). Setmelanotide and somatropin are the calm ones: no embryo-fetal harm in rats at up to 11 times human exposure for setmelanotide[9](https://pepvault.app/guides/peptides-and-pregnancy#source-9), none in rats or rabbits at about 19 to 24 times human doses for somatropin[12](https://pepvault.app/guides/peptides-and-pregnancy#source-12). For the GLP-1 drugs in depth, with the exposure studies and breastfeeding, read pepvault.app/guides/glp-1s-and-pregnancy; metformin and LDN have their own pregnancy guides.

## Is BPC-157 or TB-500 safe in pregnancy?

Nobody knows, and that is the plain state of the evidence. BPC-157, TB-500, CJC-1295, ipamorelin and injected GHK-Cu have no FDA label, so there is no pregnancy section to read. Retatrutide, still in Lilly's trials, has no label yet either.

A 2025 systematic review of BPC-157 gathered 36 studies: 35 in animals or cells and one in people, 12 patients with knee pain. It found no clinical safety data in humans, let alone in pregnancy[15](https://pepvault.app/guides/peptides-and-pregnancy#source-15). The animal safety studies it read reported no harm across several organ systems; those are animal results[15](https://pepvault.app/guides/peptides-and-pregnancy#source-15). A research peptide has no label summing up animal reproduction studies like the rat, rabbit and dog work quoted above, and the review adds that harm is possible from unregulated manufacturing and contamination as well as from unknown safety[15](https://pepvault.app/guides/peptides-and-pregnancy#source-15). The human studies that do exist are in pepvault.app/guides/bpc-157-human-data.

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The Getting started path

- [What are peptides? Are they steroids, and are they safe?](https://pepvault.app/guides/what-are-peptides)
- [How to reconstitute peptides](https://pepvault.app/guides/how-to-reconstitute-peptides)
- [What is bacteriostatic water?](https://pepvault.app/guides/bacteriostatic-water-explained)
- [How to read an insulin syringe](https://pepvault.app/guides/how-to-read-an-insulin-syringe)
- [How to reconstitute tirzepatide](https://pepvault.app/guides/how-to-reconstitute-tirzepatide)
- [How to reconstitute semaglutide](https://pepvault.app/guides/how-to-reconstitute-semaglutide)
- [How to reconstitute retatrutide](https://pepvault.app/guides/how-to-reconstitute-retatrutide)
- [How many units is 2.5 mg of tirzepatide?](https://pepvault.app/guides/how-many-units-is-2-5-mg)
- [Can you mix peptides in the same syringe?](https://pepvault.app/guides/mixing-peptides-in-one-syringe)
- [Where to inject peptides under the skin](https://pepvault.app/guides/where-to-inject-peptides)
- [How to store peptides at home and on trips](https://pepvault.app/guides/how-to-store-peptides)
- [What to take alongside each peptide](https://pepvault.app/guides/what-to-take-with-peptides)
- [How to read a peptide COA, line by line](https://pepvault.app/guides/how-to-read-a-peptide-coa)
- [How to read a peptide study](https://pepvault.app/guides/how-to-read-a-peptide-study)
- [Injection site rotation: a plan for daily, weekly and twice-daily shots](https://pepvault.app/guides/injection-site-rotation)
- [Peptide pens vs vials: which is better?](https://pepvault.app/guides/peptide-pens-vs-vials)
- [Peptide half-life explained, with a chart of real half-lives](https://pepvault.app/guides/peptide-half-life-explained)
- [Peptide side effects: what to expect in general](https://pepvault.app/guides/peptide-side-effects)
- [Peptide therapy: what clinics offer, what is proven, cost and insurance](https://pepvault.app/guides/peptide-therapy)
- [Blood tests before starting a GLP-1 or a peptide, and which to repeat](https://pepvault.app/guides/blood-tests-before-starting)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Growth hormone (GH)](https://pepvault.app/glossary/growth-hormone)
- [Contraindication](https://pepvault.app/glossary/contraindication)
- [MASH](https://pepvault.app/glossary/mash)

## How long do peptides stay in your body before trying to conceive?

That depends on the **half-life**, the time for half of the drug in the blood to be cleared (pepvault.app/glossary/half-life). After one half-life half remains; after five, about 3%. The spread across peptides is huge, from minutes for tesamorelin to about a week for semaglutide.

| Peptide | Half-life in people | Five half-lives (about 97% gone) |
| --- | --- | --- |
| Semaglutide (Ozempic, Wegovy) | About 1 week[1](https://pepvault.app/guides/peptides-and-pregnancy#source-1) [2](https://pepvault.app/guides/peptides-and-pregnancy#source-2) | About 5 weeks; the Wegovy label says 5 to 7 weeks[2](https://pepvault.app/guides/peptides-and-pregnancy#source-2) |
| Retatrutide | About 6 days, in a phase 1b trial[16](https://pepvault.app/guides/peptides-and-pregnancy#source-16) | About 30 days |
| Tirzepatide (Mounjaro, Zepbound) | About 5 days; 5 to 6 days with obesity[3](https://pepvault.app/guides/peptides-and-pregnancy#source-3) [4](https://pepvault.app/guides/peptides-and-pregnancy#source-4) | 25 to 30 days |
| CJC-1295 with DAC | 5.8 to 8.1 days[17](https://pepvault.app/guides/peptides-and-pregnancy#source-17) | 29 to 41 days |
| hCG | 32 to 33 hours[18](https://pepvault.app/guides/peptides-and-pregnancy#source-18) | About 7 days |
| Liraglutide (Saxenda) | About 13 hours[5](https://pepvault.app/guides/peptides-and-pregnancy#source-5) | About 3 days |
| Setmelanotide (Imcivree) | About 11 hours[9](https://pepvault.app/guides/peptides-and-pregnancy#source-9) | About 2 days |
| Somatropin (HGH) | 3 hours under the skin[12](https://pepvault.app/guides/peptides-and-pregnancy#source-12) | About 15 hours |
| Bremelanotide (PT-141) | About 2.7 hours[8](https://pepvault.app/guides/peptides-and-pregnancy#source-8) | About 14 hours |
| Ipamorelin | 2 hours, by vein in healthy men[19](https://pepvault.app/guides/peptides-and-pregnancy#source-19) | About 10 hours |
| Tesamorelin (Egrifta) | 8 to 11 minutes[6](https://pepvault.app/guides/peptides-and-pregnancy#source-6) [7](https://pepvault.app/guides/peptides-and-pregnancy#source-7) | Under an hour |
| BPC-157 | Not measured in people; under 30 minutes in animals[15](https://pepvault.app/guides/peptides-and-pregnancy#source-15) | No human figure |

Read the right-hand column as arithmetic, not as a stop date. Only semaglutide's labels turn it into one: their 2 months covers the 5 weeks (Ozempic) to 5 to 7 weeks (Wegovy) it stays in the blood, with a margin[1](https://pepvault.app/guides/peptides-and-pregnancy#source-1) [2](https://pepvault.app/guides/peptides-and-pregnancy#source-2). The effect can also outlast the drug: after repeated doses of CJC-1295 with DAC, IGF-1, the growth factor it raises, stayed above baseline for up to 28 days[17](https://pepvault.app/guides/peptides-and-pregnancy#source-17). Each compound's own page shows the curve, for example pepvault.app/peptides/tirzepatide/half-life and pepvault.app/peptides/bpc-157/half-life. Which date applies to you is your prescriber's decision.

<!--promo-->

PepVault's dose log keeps the date and amount of every dose you log, for each compound, so your last dose is on record when your prescriber asks how long it has been. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-peptides-and-pregnancy-inline&mt=8)

<!--/promo-->

## Do men need to stop peptides before trying to conceive?

No label in the table sets a stop date for a man. Their stop-before and birth-control lines are written for the person who will carry the pregnancy[1](https://pepvault.app/guides/peptides-and-pregnancy#source-1) [2](https://pepvault.app/guides/peptides-and-pregnancy#source-2) [3](https://pepvault.app/guides/peptides-and-pregnancy#source-3) [4](https://pepvault.app/guides/peptides-and-pregnancy#source-4) [8](https://pepvault.app/guides/peptides-and-pregnancy#source-8). What the labels hold for men are rat fertility studies. Semaglutide had no effect on male fertility[1](https://pepvault.app/guides/peptides-and-pregnancy#source-1), tirzepatide none on sperm shape, mating or conception[3](https://pepvault.app/guides/peptides-and-pregnancy#source-3), liraglutide no direct effect at 11 times human exposure[5](https://pepvault.app/guides/peptides-and-pregnancy#source-5), and tesamorelin none in male or female rats[6](https://pepvault.app/guides/peptides-and-pregnancy#source-6).

Somatropin is the exception at high doses: at about 24 times the human dose, male rats made fewer and less motile sperm, with no effect at about 2 times[12](https://pepvault.app/guides/peptides-and-pregnancy#source-12). All of these are rat results. hCG runs the other way, as a fertility treatment: its label lists it for men whose low testosterone comes from the pituitary (pepvault.app/peptides/hcg)[10](https://pepvault.app/guides/peptides-and-pregnancy#source-10). For BPC-157 there are no human safety data of any kind, in men or women[15](https://pepvault.app/guides/peptides-and-pregnancy#source-15).

## What if you find out you're pregnant while taking a peptide?

It most often happens in the weeks before a positive test. The labels' first step is the same: stop the weight and fat drugs once the pregnancy is known (Wegovy, Zepbound, Saxenda, Egrifta), stop Vyleesi if pregnancy is even suspected, and stop Imcivree unless the benefit outweighs the risk[2](https://pepvault.app/guides/peptides-and-pregnancy#source-2) [4](https://pepvault.app/guides/peptides-and-pregnancy#source-4) [5](https://pepvault.app/guides/peptides-and-pregnancy#source-5) [6](https://pepvault.app/guides/peptides-and-pregnancy#source-6) [8](https://pepvault.app/guides/peptides-and-pregnancy#source-8) [9](https://pepvault.app/guides/peptides-and-pregnancy#source-9). On a diabetes drug such as Ozempic or Mounjaro, the call is the prescriber's, because blood sugar control matters for the baby too[1](https://pepvault.app/guides/peptides-and-pregnancy#source-1) [3](https://pepvault.app/guides/peptides-and-pregnancy#source-3).

The human numbers are small. Across Vyleesi's trials in more than 1,057 women, 7 pregnancies were reported: no major birth defects, five full-term births, one miscarriage and one lost to follow-up[8](https://pepvault.app/guides/peptides-and-pregnancy#source-8). For scale, the labels give the background risk in any US pregnancy: 2% to 4% for a major birth defect and 15% to 20% for a miscarriage[8](https://pepvault.app/guides/peptides-and-pregnancy#source-8). Wegovy and Zepbound each run a pregnancy registry that collects outcomes, and their labels ask exposed patients to report to it[2](https://pepvault.app/guides/peptides-and-pregnancy#source-2) [4](https://pepvault.app/guides/peptides-and-pregnancy#source-4).

**Commonly reported:** surprise pregnancies after the weight came off on a GLP-1, worry after a few weeks of BPC-157 before a positive test, and confusion over how long to wait after a research peptide, a question no label answers.

**When to get help** A positive test while taking any of these is a reason to call your prescriber or obstetrician that week, and anyone taking a peptide for diabetes should ask before stopping it.

## What should you ask your prescriber before trying to conceive?

- Which of my peptides has an FDA label, and what does its pregnancy section say?
- If I take semaglutide, which day should my last dose be, given the label's 2 months?
- If I take the pill and start or step up tirzepatide, what do I use for the 4 weeks after?
- For a research peptide with no label, how long should I stop before trying, and on what basis?
- If I take a peptide for diabetes, what replaces it before and during pregnancy?
- Does my partner need to stop anything?

<!--promo-->

PepVault's doctor's report lists each compound with the doses you logged, so you can bring the whole picture to that appointment on one page. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-peptides-and-pregnancy-inline&mt=8)

<!--/promo-->

Next, read pepvault.app/guides/glp-1s-and-pregnancy for the semaglutide and tirzepatide studies in full.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Novo Nordisk. OZEMPIC (semaglutide) injection, prescribing information (DailyMed, SPL version 20, effective Jun 1, 2026): sections 8.1, 8.3, 12.3 and 13.1. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
2. Novo Nordisk. WEGOVY (semaglutide) injection and tablets, prescribing information (DailyMed, SPL version 19, effective Jun 18, 2026): sections 8.1, 8.3, 12.3 and 13.1. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
3. Eli Lilly and Company. MOUNJARO (tirzepatide) injection, prescribing information (DailyMed, SPL version 40, effective Aug 27, 2026): sections 7.2, 8.1, 8.3, 12.3 and 13.1. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
4. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, prescribing information (DailyMed, SPL version 40, effective Aug 28, 2026): sections 7.2, 8.1, 8.3, 12.3 and 13.1. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
5. Novo Nordisk. SAXENDA (liraglutide) injection, prescribing information (DailyMed, SPL version 22, effective Feb 25, 2026): sections 8.1, 12.3 and 13.1. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143)
6. Theratechnologies. EGRIFTA SV (tesamorelin) for injection, prescribing information (DailyMed, SPL version 9, effective Jul 29, 2026): sections 4, 8.1, 12.3 and 13.1. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d783378-b02d-4f19-99dd-0fc91a042224)
7. Theratechnologies. EGRIFTA WR (tesamorelin) for injection, prescribing information (DailyMed, SPL version 2, effective Jul 29, 2026): sections 4, 8.1 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75)
8. Cosette Pharmaceuticals. VYLEESI (bremelanotide) injection, prescribing information (DailyMed, SPL version 2, effective Nov 5, 2026): sections 8.1, 8.3 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf)
9. Rhythm Pharmaceuticals. IMCIVREE (setmelanotide) injection, prescribing information (DailyMed, SPL version 14, effective Apr 1, 2026): sections 8.1 and 12.3. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9)
10. Ferring Pharmaceuticals. NOVAREL (chorionic gonadotropin) for injection, prescribing information (DailyMed, SPL version 41, effective Aug 27, 2025): indications, contraindications and pregnancy. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac6918ff-9dc3-40d9-8619-54b26e4bdfc8)
11. Organon. PREGNYL (chorionic gonadotropin) for injection, prescribing information (DailyMed, SPL version 11, effective Dec 2, 2025): pregnancy. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e94155f-19be-4944-b197-be4edbb4faf9)
12. Pfizer. GENOTROPIN (somatropin) for injection, prescribing information (DailyMed, SPL version 37, effective Aug 4, 2026): sections 8.1, 12.3 and 13.1. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ffebf88b-d257-4542-9808-74d9b7167765)
13. Novo Nordisk. NOVOLOG MIX 70/30 (insulin aspart protamine and insulin aspart) injection, prescribing information (DailyMed, SPL version 25, effective Feb 28, 2023): section 8.1. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1861fcee-7673-4afe-a206-08fa05c0add2)
14. Par Health. PITOCIN (oxytocin) injection, prescribing information (DailyMed, SPL version 16, effective May 6, 2026): pregnancy. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=969d5b35-0add-4c23-9605-6a5b6ab65c95)
15. Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS J. 2025;21(4):485-495. [PubMed 40756949](https://pubmed.ncbi.nlm.nih.gov/40756949/)
16. Urva S, Coskun T, Loh MT, et al. LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial. Lancet. 2022;400(10366):1869-1881. [PubMed 36354040](https://pubmed.ncbi.nlm.nih.gov/36354040/)
17. Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805. [PubMed 16352683](https://pubmed.ncbi.nlm.nih.gov/16352683/)
18. Mannaerts BM, Geurts TB, Odink J. A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration. Hum Reprod. 1998;13(6):1461-1464. [PubMed 9688371](https://pubmed.ncbi.nlm.nih.gov/9688371/)
19. Gobburu JV, Agersø H, Jusko WJ, Ynddal L. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res. 1999;16(9):1412-1416. [PubMed 10496658](https://pubmed.ncbi.nlm.nih.gov/10496658/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · Getting started

Guide · Getting started

### [Blood tests before starting a GLP-1 or a peptide, and which to repeat](https://pepvault.app/guides/blood-tests-before-starting)

What the FDA labels for Ozempic, Wegovy, Mounjaro, Zepbound, tesamorelin, growth hormone and testosterone test before the first dose and which they repeat.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Liraglutide Studied range: 0.6–3 mg](https://pepvault.app/peptides/liraglutide)
- [Tesamorelin Studied range: 1–2 mg](https://pepvault.app/peptides/tesamorelin)
- [PT-141 Studied range: 0.5–2 mg](https://pepvault.app/peptides/pt-141)
- [Setmelanotide Studied range: 0.5–3 mg](https://pepvault.app/peptides/setmelanotide)
- [HCG Studied range: 250–500 IU](https://pepvault.app/peptides/hcg)
- [HGH Studied range: 1–4 IU](https://pepvault.app/peptides/hgh)
- [BPC-157 Studied range: 200–500 mcg](https://pepvault.app/peptides/bpc-157)
- [TB-500 Studied range: 1–2.5 mg](https://pepvault.app/peptides/tb-500)
- [Retatrutide Studied range: 1–12 mg](https://pepvault.app/peptides/retatrutide)
- [CJC-1295 with DAC Studied range: 1–2 mg](https://pepvault.app/peptides/cjc-1295-with-dac)
- [Ipamorelin Studied range: 200–300 mcg](https://pepvault.app/peptides/ipamorelin)
- [Oxytocin Studied range: 10–40 IU](https://pepvault.app/peptides/oxytocin)

## Related guides

- Guide · GLP-1s

  ### [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)

  Ozempic, Wegovy, Mounjaro and Zepbound in pregnancy: each label's stop-before line, the pill warning, breastfeeding, wash-out times and what 2026 studies found.

  Read the guide
- Guide · Longevity and supplements

  ### [Is metformin safe in pregnancy, and before trying to conceive?](https://pepvault.app/guides/metformin-and-pregnancy)

  Metformin in pregnancy and before conceiving: the label's lines, the MiG, PregMet and MiTy trial numbers, how the children grew, and how GLP-1 labels differ.

  Read the guide
- Guide · The science

  ### [Is low-dose naltrexone (LDN) safe in pregnancy, and before trying to conceive?](https://pepvault.app/guides/ldn-and-pregnancy)

  LDN in pregnancy and before IVF: each naltrexone label's own pregnancy and breastfeeding lines, the human studies, the fertility trials and how fast it clears.

  Read the guide
- Guide · Recovery

  ### [BPC-157: the human data we have](https://pepvault.app/guides/bpc-157-human-data)

  Every published human study of BPC-157: the knee pain, bladder pain and IV safety pilots, what each found, the trials now registered, and how it works.

  Read the guide
- Guide · Hormones and blood tests

  ### [hCG vs hMG vs enclomiphene: what each one is and does](https://pepvault.app/guides/hcg-vs-hmg-vs-enclomiphene)

  hCG stands in for LH, hMG adds FSH for sperm, enclomiphene makes your own pituitary send both. What each is approved for and what its trials measured.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The Getting started path

- [What are peptides? Are they steroids, and are they safe?](https://pepvault.app/guides/what-are-peptides)
- [How to reconstitute peptides](https://pepvault.app/guides/how-to-reconstitute-peptides)
- [What is bacteriostatic water?](https://pepvault.app/guides/bacteriostatic-water-explained)
- [How to read an insulin syringe](https://pepvault.app/guides/how-to-read-an-insulin-syringe)
- [How to reconstitute tirzepatide](https://pepvault.app/guides/how-to-reconstitute-tirzepatide)
- [How to reconstitute semaglutide](https://pepvault.app/guides/how-to-reconstitute-semaglutide)
- [How to reconstitute retatrutide](https://pepvault.app/guides/how-to-reconstitute-retatrutide)
- [How many units is 2.5 mg of tirzepatide?](https://pepvault.app/guides/how-many-units-is-2-5-mg)
- [Can you mix peptides in the same syringe?](https://pepvault.app/guides/mixing-peptides-in-one-syringe)
- [Where to inject peptides under the skin](https://pepvault.app/guides/where-to-inject-peptides)
- [How to store peptides at home and on trips](https://pepvault.app/guides/how-to-store-peptides)
- [What to take alongside each peptide](https://pepvault.app/guides/what-to-take-with-peptides)
- [How to read a peptide COA, line by line](https://pepvault.app/guides/how-to-read-a-peptide-coa)
- [How to read a peptide study](https://pepvault.app/guides/how-to-read-a-peptide-study)
- [Injection site rotation: a plan for daily, weekly and twice-daily shots](https://pepvault.app/guides/injection-site-rotation)
- [Peptide pens vs vials: which is better?](https://pepvault.app/guides/peptide-pens-vs-vials)
- [Peptide half-life explained, with a chart of real half-lives](https://pepvault.app/guides/peptide-half-life-explained)
- [Peptide side effects: what to expect in general](https://pepvault.app/guides/peptide-side-effects)
- [Peptide therapy: what clinics offer, what is proven, cost and insurance](https://pepvault.app/guides/peptide-therapy)
- [Blood tests before starting a GLP-1 or a peptide, and which to repeat](https://pepvault.app/guides/blood-tests-before-starting)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Growth hormone (GH)](https://pepvault.app/glossary/growth-hormone)
- [Contraindication](https://pepvault.app/glossary/contraindication)
- [MASH](https://pepvault.app/glossary/mash)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
